Monopar Therapeutics (MNPR) said Friday it has priced an offering of shares and and pre-funded warrants to raise $40 million.
Monopar said it priced the underwritten registered offering of 798,655 shares at $23.79 per share and the private placement of warrants to purchase 882,761 shares at $23.789 per pre-funded warrant.
The offering is set to close Monday, with Piper Sandler as the book-running manager, the clinical-stage company. It plans to use the proceeds for general corporate purposes and working capital.
Monopar shares were up about 2% in recent trading.
Price: 24.29, Change: +0.50, Percent Change: +2.09
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。